The impact of metabolic control on cognition, neurophysiology, and well-being in PKU: A systematic review and meta-analysis of the within-participant literature
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The impact of metabolic control on cognition, neurophysiology, and well-being in PKU: A systematic review and meta-analysis of the within-participant literature
Authors
Keywords
-
Journal
MOLECULAR GENETICS AND METABOLISM
Volume 138, Issue 1, Pages 106969
Publisher
Elsevier BV
Online
2022-12-13
DOI
10.1016/j.ymgme.2022.106969
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long‐term cognitive and psychosocial outcomes in adults with phenylketonuria
- (2021) Lynne Aitkenhead et al. JOURNAL OF INHERITED METABOLIC DISEASE
- The neurological and neuropsychiatric spectrum of adults with late-treated phenylketonuria
- (2021) Tina Mainka et al. PARKINSONISM & RELATED DISORDERS
- White matter disturbances in phenylketonuria: Possible underlying mechanisms
- (2020) Bruna Klippel Ferreira et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Inter- and intra-tract analysis of white matter abnormalities in individuals with early-treated phenylketonuria (PKU)
- (2020) Hayley E. Clocksin et al. MOLECULAR GENETICS AND METABOLISM
- Neuropsychological Profile of Children with Early and Continuously Treated Phenylketonuria: Systematic Review and Future Approaches
- (2019) Marie Canton et al. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
- Emotional health in early-treated adults with phenylketonuria (PKU): Relationship with cognitive abilities and blood phenylalanine
- (2019) Liana Palermo et al. JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY
- Neurological manifestations in adults with phenylketonuria: new cases and review of the literature
- (2019) Paul Jaulent et al. JOURNAL OF NEUROLOGY
- Adult cognitive outcomes in phenylketonuria: explaining causes of variability beyond average Phe levels
- (2019) Cristina Romani et al. Orphanet Journal of Rare Diseases
- Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM)
- (2018) Janet Thomas et al. MOLECULAR GENETICS AND METABOLISM
- Pegvaliase for the treatment of phenylketonuria: A pivotal, double-blind randomized discontinuation Phase 3 clinical trial
- (2018) Cary O. Harding et al. MOLECULAR GENETICS AND METABOLISM
- Can untreated PKU patients escape from intellectual disability? A systematic review
- (2018) Danique van Vliet et al. Orphanet Journal of Rare Diseases
- A systematic review of cognitive functioning in early treated adults with phenylketonuria
- (2018) Denise Leonne Hofman et al. Orphanet Journal of Rare Diseases
- Cognitive profile and mental health in adult phenylketonuria: A PKU-COBESO study.
- (2017) Rianne Jahja et al. NEUROPSYCHOLOGY
- The impact of phenylalanine levels on cognitive outcomes in adults with phenylketonuria: Effects across tasks and developmental stages.
- (2017) Cristina Romani et al. NEUROPSYCHOLOGY
- The complete European guidelines on phenylketonuria: diagnosis and treatment
- (2017) A. M. J. van Wegberg et al. Orphanet Journal of Rare Diseases
- Key European guidelines for the diagnosis and management of patients with phenylketonuria
- (2017) Francjan J van Spronsen et al. Lancet Diabetes & Endocrinology
- Systematic Review and Meta-Analysis of Neuropsychiatric Symptoms and Executive Functioning in Adults With Phenylketonuria
- (2016) Deborah A. Bilder et al. DEVELOPMENTAL NEUROPSYCHOLOGY
- Neurocognitive and neuroimaging outcome of early treated young adult PKU patients: A longitudinal study
- (2015) Francesca Nardecchia et al. MOLECULAR GENETICS AND METABOLISM
- The outcome of white matter abnormalities in early treated phenylketonuric patients: A retrospective longitudinal long-term study
- (2015) Mario Mastrangelo et al. MOLECULAR GENETICS AND METABOLISM
- A randomized, placebo-controlled, double-blind study of sapropterin to treat ADHD symptoms and executive function impairment in children and adults with sapropterin-responsive phenylketonuria
- (2015) B. Burton et al. MOLECULAR GENETICS AND METABOLISM
- Quality of Life (QoL) assessment in a cohort of patients with Phenylketonuria
- (2014) Chiara Cazzorla et al. BMC PUBLIC HEALTH
- Phenylalanine hydroxylase deficiency: diagnosis and management guideline
- (2014) GENETICS IN MEDICINE
- Newborn screening 50 years later: access issues faced by adults with PKU
- (2013) Susan A. Berry et al. GENETICS IN MEDICINE
- Longitudinal quality of life analysis in a phenylketonuria cohort provided sapropterin dihydrochloride
- (2013) Teresa D Douglas et al. Health and Quality of Life Outcomes
- A Pilot Study of Fluorodeoxyglucose Positron Emission Tomography Findings in Patients with Phenylketonuria before and during Sapropterin Supplementation
- (2013) Can Ficicioglu et al. Journal of Clinical Neurology
- White matter integrity and executive abilities following treatment with tetrahydrobiopterin (BH4) in individuals with phenylketonuria
- (2013) Desirée A. White et al. MOLECULAR GENETICS AND METABOLISM
- White matter integrity and executive abilities in individuals with phenylketonuria
- (2013) Jo Ann V. Antenor-Dorsey et al. MOLECULAR GENETICS AND METABOLISM
- A diversified approach for PKU treatment: Routine screening yields high incidence of psychiatric distress in phenylketonuria clinics
- (2012) Barbara K. Burton et al. MOLECULAR GENETICS AND METABOLISM
- Tackling frontal lobe–related functions in PKU through functional brain imaging: a Stroop task in adult patients
- (2011) Benedikt Sundermann et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Dietary treatment of phenylketonuria: the effect of phenylalanine on reaction time
- (2011) Charlotte Dawson et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Cognitive, neurophysiological, neurological and psychosocial outcomes in early-treated PKU-patients: A start toward standardized outcome measurement across development
- (2011) F.J. van Spronsen et al. MOLECULAR GENETICS AND METABOLISM
- Neurological complications and behavioral problems in patients with phenylketonuria in a Follow-up Unit
- (2011) María J. González et al. MOLECULAR GENETICS AND METABOLISM
- High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled, crossover trial
- (2010) Amber E. ten Hoedt et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Phenylketonuria
- (2010) Nenad Blau et al. LANCET
- Routine use of CANTAB system for detection of neuropsychological deficits in patients with PKU
- (2010) Miroslaw Bik-Multanowski et al. MOLECULAR GENETICS AND METABOLISM
- Adults with late diagnosed PKU and severe challenging behaviour: a randomised placebo-controlled trial of a phenylalanine-restricted diet
- (2009) P J Lee et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- White matter pathology in phenylketonuria☆
- (2009) Peter J. Anderson et al. MOLECULAR GENETICS AND METABOLISM
- Executive function in early-treated phenylketonuria: Profile and underlying mechanisms☆☆☆
- (2009) Shawn E. Christ et al. MOLECULAR GENETICS AND METABOLISM
- Does maternal knowledge and parent education affect blood phenylalanine control in phenylketonuria?
- (2008) A. MacDonald et al. JOURNAL OF HUMAN NUTRITION AND DIETETICS
- Quality of life in noncompliant adults with phenylketonuria after resumption of the diet
- (2008) M. Bik-Multanowski et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Neuropsychological speed tests and blood phenylalanine levels in patients with phenylketonuria: A meta-analysis
- (2008) Julia Albrecht et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now